Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR1 | P21554 | 5/20 | 0.78 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.78 |
| ▸ | MEN1 | O00255 | 3/20 | 0.78 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.78 |
| ▸ | HPGD | P15428 | 2/20 | 0.78 |
| ▸ | TRPV1 | Q8NER1 | 2/20 | 0.78 |
| ▸ | BLM | P54132 | 2/20 | 0.78 |
| ▸ | MAPT | P10636 | 1/20 | 0.78 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.78 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.78 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.74 |
| ▸ | TRPM8 | Q7Z2W7 | 1/20 | 0.71 |
| ▸ | FAAH | O00519 | 1/20 | 0.71 |
| ▸ | KCNK3 | O14649 | 1/20 | 0.71 |
| ▸ | CNR2 | P34972 | 1/20 | 0.71 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18157801 | 1.00 | CNR1 (0.78) | CNR1ALDH1A1MEN1KMT2AHPGD | |
| SCHEMBL2220077 | 0.95 | EPHX2 (0.72) | CNR1ALDH1A1MEN1KMT2AHPGD | |
| SCHEMBL2328289 | 0.95 | EPHX2 (0.72) | CNR1ALDH1A1MEN1KMT2AHPGD | |
| SCHEMBL9803810 | 0.95 | EPHX2 (0.72) | CNR1ALDH1A1MEN1KMT2AHPGD | |
| SCHEMBL18863614 | 0.95 | EPHX2 (0.72) | CNR1ALDH1A1MEN1KMT2AHPGD | |
| SCHEMBL23492978 | 0.95 | EPHX2 (0.72) | CNR1ALDH1A1MEN1KMT2AHPGD | |
| SCHEMBL9803815 | 0.95 | EPHX2 (0.72) | CNR1ALDH1A1MEN1KMT2AHPGD | |
| SCHEMBL1067684 | 0.95 | CNR1 (0.85) | CNR1ALDH1A1MEN1KMT2AHPGD | |
| SCHEMBL30802593 | 0.95 | EPHX2 (0.72) | CNR1ALDH1A1MEN1KMT2AHPGD | |
| SCHEMBL9716724 | 0.92 | EPHX2 (0.73) | CNR1ALDH1A1MEN1KMT2AHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260083682-A1 | KIT FOR MANUFACTURE OF DRUG-CONTAINING NANOPARTICLES AND NANOPARTICLE COMPOSITION FOR DRUG DELIVERY | SAMYANG HOLDINGS CORPORATION (KR) | 2026-03-26 | — | — | US | disclosed |
| US-12551452-B2 | Kit for preparing nanoparticle composition for drug delivery, comprising polylactic acid salt | SAMYANG HOLDINGS CORPORATION (KR) | 2026-02-17 | — | — | US | disclosed |
| EP-4585212-A1 | KIT FOR MANUFACTURE OF DRUG-CONTAINING NANOPARTICLES AND NANOPARTICLE COMPOSITION FOR DRUG DELIVERY | Samyang Holdings Corporation (KR) | 2025-07-16 | — | — | EP | disclosed |
| US-20240366786-A1 | COMPOSITION FOR DRUG DELIVERY COMPRISING NANOPARTICLES NOT CONTAINING AMPHIPHILIC POLYMER | SAMYANG HOLDINGS CORPORATION (KR) | 2024-11-07 | — | — | US | disclosed |
| US-20240366520-A1 | KIT FOR PREPARING NANOPARTICLES CONTAINING DRUG AND COMPRISING NO AMPHIPHILIC POLYMERS | SAMYANG HOLDINGS CORPORATION (KR) | 2024-11-07 | — | — | US | disclosed |
| WO-2024053862-A1 | KIT FOR MANUFACTURE OF DRUG-CONTAINING NANOPARTICLES AND NANOPARTICLE COMPOSITION FOR DRUG DELIVERY | 주식회사 삼양홀딩스 | 2024-03-14 | — | — | WO | disclosed |
| EP-3834822-B1 | POLYMER NANOPARTICLE COMPOSITION FOR DELIVERING VIRUS, AND PREPARATION METHOD THEREFOR | SAMYANG HOLDINGS CORP (KR) | 2023-10-25 | — | — | EP | disclosed |
| US-20230039124-A1 | KIT FOR PREPARING NANOPARTICLE COMPOSITION FOR DRUG DELIVERY, COMPRISING POLYLACTIC ACID SALT | SAMYANG HOLDINGS CORPORATION (KR) | 2023-02-09 | — | — | US | disclosed |
| US-20220409710-A1 | POLYMER NANOPARTICLE COMPOSITION FOR INDUCING IMMUNITY AND PREPARATION METHOD THEREFOR | SAMYANG HOLDINGS CORPORATION (KR) | 2022-12-29 | — | — | US | disclosed |
| WO-2022231375-A1 | COMPOSITION FOR DRUG DELIVERY COMPRISING NANOPARTICLES NOT CONTAINING AMPHIPHILIC POLYMER | 주식회사 삼양홀딩스 | 2022-11-03 | — | — | WO | disclosed |
| WO-2022231374-A1 | KIT FOR PREPARING NANOPARTICLES CONTAINING DRUG AND COMPRISING NO AMPHIPHILIC POLYMERS | 주식회사 삼양홀딩스 | 2022-11-03 | — | — | WO | disclosed |
| EP-4079298-A1 | KIT FOR PREPARING NANOPARTICLE COMPOSITION FOR DRUG DELIVERY, COMPRISING POLYLACTIC ACID SALT | Samyang Holdings Corporation (KR) | 2022-10-26 | — | — | EP | disclosed |
| EP-4062908-A1 | KIT FOR PREPARING NANOPARTICLE COMPOSITION FOR DRUG DELIVERY | Samyang Holdings Corporation (KR) | 2022-09-28 | — | — | EP | disclosed |
| EP-4056174-A1 | POLYMER NANOPARTICLE COMPOSITION FOR INDUCING IMMUNITY AND PREPARATION METHOD THEREFOR | Samyang Holdings Corporation (KR) | 2022-09-14 | — | — | EP | disclosed |
| US-20220257679-A1 | POLYMER NANOPARTICLE COMPOSITION FOR DELIVERING VIRUS, AND PREPARATION METHOD THEREFOR | SAMYANG HOLDINGS CORPORATION (KR) | 2022-08-18 | — | — | US | disclosed |
| EP-3834822-A1 | POLYMER NANOPARTICLE COMPOSITION FOR DELIVERING VIRUS, AND PREPARATION METHOD THEREFOR | Samyang Biopharmaceuticals Corporation (KR) | 2021-06-16 | — | — | EP | disclosed |
| WO-2020032581-A1 | POLYMER NANOPARTICLE COMPOSITION FOR DELIVERING VIRUS, AND PREPARATION METHOD THEREFOR | 주식회사 삼양바이오팜 | 2020-02-13 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240366520-A1 | KIT FOR PREPARING NANOPARTICLES CONTAINING DRUG AND COMPRISING NO AMPHIPHILIC POLYMERS | KIT, ABCB1, KPNA6 | CNR1 4401/4885ALDH1A1 2614/4885MEN1 668/4885 |
| US-12551452-B2 | Kit for preparing nanoparticle composition for drug delivery, comprising polylactic acid salt | KIT, IRAK1, JAK1 | CNR1 3627/4885ALDH1A1 2975/4885MEN1 1874/4885 |
| US-20240366786-A1 | COMPOSITION FOR DRUG DELIVERY COMPRISING NANOPARTICLES NOT CONTAINING AMPHIPHILIC POLYMER | ABCB11, ABCB1, SLC47A1 | CNR1 3262/4885ALDH1A1 3379/4885MEN1 1606/4885 |
| US-20220257679-A1 | POLYMER NANOPARTICLE COMPOSITION FOR DELIVERING VIRUS, AND PREPARATION METHOD THEREFOR | FURIN, THEM6, PRNP | CNR1 4499/4885ALDH1A1 3305/4885MEN1 1768/4885 |
| US-20230039124-A1 | KIT FOR PREPARING NANOPARTICLE COMPOSITION FOR DRUG DELIVERY, COMPRISING POLYLACTIC ACID SALT | KIT, KPNA6, KNTC1 | CNR1 4658/4885ALDH1A1 2758/4885MEN1 582/4885 |
| US-20220409710-A1 | POLYMER NANOPARTICLE COMPOSITION FOR INDUCING IMMUNITY AND PREPARATION METHOD THEREFOR | MYD88, NOD1, NOD2 | CNR1 3897/4885ALDH1A1 4801/4885MEN1 2463/4885 |
| US-20260083682-A1 | KIT FOR MANUFACTURE OF DRUG-CONTAINING NANOPARTICLES AND NANOPARTICLE COMPOSITION FOR DRUG DELIVERY | KIT, ABCC1, CD81 | CNR1 2545/4885ALDH1A1 1235/4885MEN1 2403/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.